UNIKUM Therapeutics ApS
Private limited companyCVR 41192925RisskovActive
UNIKUM Therapeutics ApS is a private limited company, based in Risskov, active in research and experimental development on natural sciences and engineering, founded in 2020. Equity was negative at the end of 2025 (−DKK 5.7m). The company made a loss in both 2024 and 2025, most recently DKK 859k.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 13.8m to DKK 859k (2024 → 2025).
Employees
- 9 fewer employees than a year earlier: 2 (01/2025) against 11 (01/2024).
Management and owners, last 24 months
- Stepped down: Nebojsa Milovic (board member, 27/05/2025) and Margo Rosemary Roberts (board member, 27/05/2025).
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
- 27/11/2024: Moved to Kanehaven 33, 8240 Risskov
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | −1,099 | −2,726 | −3,315 | −7,465 | −7,368 | −248 | +96.6% |
| Operating profit (EBIT) | −2,289 | −6,427 | −8,184 | −15,375 | −15,257 | −362 | +97.6% |
| Profit before tax | −2,436 | −7,028 | −8,903 | −16,726 | −15,914 | −895 | +94.4% |
| Net profit | −2,132 | −5,555 | −7,649 | −14,871 | −13,797 | −859 | +93.8% |
| Total assets | 2,263 | 6,700 | 3,057 | 3,996 | 3,759 | 138 | −96.3% |
| Equity | −2,092 | −7,645 | −15,294 | −16,284 | −4,821 | −5,680 | −17.8% |
| Liabilities | 4,355 | 14,345 | 18,351 | 20,280 | 8,580 | 5,818 | −32.2% |
| Cash and cash equivalents | 1,713 | 4,346 | 207 | 1,544 | 1,319 | 72 | −94.5% |
| Average number of employees | 2 | 5 | 7 | 9 | 9 | 0 | −100% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 5.7m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 11/03/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 27/05/2025 | The company | PDF not statedXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 25/03/2024 | The company | PDF not statedXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 11/05/2023 | The company | PDF not statedXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 20/04/2022 | The company | PDF not statedXBRL |
| 2020 | 17/02/2020 – 31/12/2020 | 31/05/2021 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 67,192of 69,742 Better than 4% | No. 69,264of 69,964 Better than 1% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 204of 323 Better than 37% | No. 291of 329 Better than 12% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 32,614of 33,588 Better than 3% | No. 33,137of 33,687 Better than 2% |
| All companies of type ApS66,508 companies in the comparison | No. 64,373of 66,379 Better than 3% | No. 65,810of 66,505 Better than 1% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- UNIKUM Therapeutics ApS−DKK 248k
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- UNIKUM Therapeutics ApS−DKK 859k
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- UNIKUM Therapeutics ApS−DKK 5.7m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- UNIKUM Therapeutics ApS2
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Medic Advice ApS5%
- RO Bak Holding ApS5%
- Volnay Therapeutics, LLC33.33%
- BII Holdings A/S5%
- MR Jakobsen Holding ApS15%
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Martin Roelsgaard Jakobsen | Director | 01/10/2024 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Martin Roelsgaard Jakobsen | Board member | 17/02/2020 |
| Ulrik Bjerl Nielsen | Chair of the board | 17/02/2020 |
| Stefan Wildt | Board member | 12/08/2024 |
- Founders
- Ulrik Bjerl Nielsen, Medic Advice ApS, Zocca Consulting ApS, MR Jakobsen Holding ApS, RO Bak Holding ApS, Anders Laustsen Holding ApS
Former management (7)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Søren Sylvester Skjærbæk | Director | 17/02/2020 | 01/04/2021 |
| Rasmus Otkjær Bak | Director | 01/04/2021 | 17/04/2023 |
| Johannes Heinrich Frühauf | Board member | 02/03/2023 | 12/08/2024 |
| Nebojsa Milovic | Board member | 02/03/2023 | 27/05/2025 |
| Rasmus Otkjær Bak | CEO | 18/04/2023 | 30/09/2023 |
| Tommi Petteri Kainu | Director | 18/04/2023 | 30/09/2024 |
| Margo Rosemary Roberts | Board member | 01/08/2023 | 27/05/2025 |
Signing rule: Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem eller en direktør eller af den samlede bestyrelse.
Address and production units
1 active production unitsKanehaven 33
8240 Risskov
| Production unit | Address | Employees | P number |
|---|---|---|---|
| UNIKUM Therapeutics ApS | Kanehaven 33, 8240 Risskov | 2 | 1025597539 |
Purpose
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler og hermed forbundet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
74 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20254 changesmanagement 2 · accounts 1 · industry 1
- ManagementMargo Rosemary Roberts stepped down as board member
- ManagementNebojsa Milovic stepped down as board member
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
202420 changesaddress 1 · management 4 · capital 2 · ownership 12 · accounts 1
- AddressMoved to Kanehaven 33, 8240 Risskov
- ManagementMartin Roelsgaard Jakobsen appointed director
- ManagementTommi Petteri Kainu stepped down as director
- ManagementStefan Wildt appointed board member
- ManagementJohannes Heinrich Frühauf stepped down as board member
- CapitalShare capital changed from 78,674 DKK to 89,038 DKK
- OwnershipMR Jakobsen Holding ApS registered as owner (15%)
- OwnershipAnders Laustsen Holding ApS is no longer registered as owner
- OwnershipUlrik Bjerl Nielsen is no longer registered as owner
- OwnershipUNIKUM Therapeutics ApS is no longer registered as owner
- OwnershipMR Jakobsen Holding ApS is no longer registered as owner
- AccountsAnnual report for 2023 published
- OwnershipBII Holdings A/S registered as owner (5%)
- OwnershipBioInnovation Institute Fonden is no longer registered as owner
- CapitalShare capital changed from 62,630 DKK to 78,674 DKK
- OwnershipVolnay Therapeutics, LLC registered as owner (33.33%)
- OwnershipBioInnovation Institute Fonden registered as owner (5%)
- OwnershipMR Jakobsen Holding ApS registered as owner (20%)
- OwnershipMR Jakobsen Holding ApS is no longer registered as owner
- OwnershipVolnay Therapeutics, LLC is no longer registered as owner
202332 changescapital 3 · ownership 21 · management 7 · accounts 1
- CapitalShare capital changed from 57,499 DKK to 62,630 DKK
- OwnershipMEDIC ADVICE ApS registered as owner (5%)
- OwnershipRO Bak Holding ApS registered as owner (5%)
- OwnershipMEDIC ADVICE ApS is no longer registered as owner
- OwnershipRO Bak Holding ApS is no longer registered as owner
- ManagementRasmus Otkjær Bak stepped down as ceo
- ManagementMargo Rosemary Roberts appointed board member
- CapitalShare capital changed from 46,980 DKK to 57,499 DKK
- OwnershipMR Jakobsen Holding ApS registered as owner (25%)
- OwnershipVolnay Therapeutics, LLC registered as owner (25%)
- OwnershipMR Jakobsen Holding ApS is no longer registered as owner
- OwnershipVolnay Therapeutics, LLC is no longer registered as owner
- AccountsAnnual report for 2022 published
- ManagementTommi Petteri Kainu appointed director
- ManagementRasmus Otkjær Bak appointed ceo
- ManagementRasmus Otkjær Bak stepped down as director
- CapitalShare capital changed from 42,105 DKK to 46,980 DKK
- ManagementNebojsa Milovic appointed board member
- ManagementJohannes Heinrich Frühauf appointed board member
- OwnershipAnders Laustsen Holding ApS registered as owner (5%)
- OwnershipUlrik Bjerl Nielsen registered as owner (5%)
- OwnershipMEDIC ADVICE ApS registered as owner (10%)
- OwnershipMR Jakobsen Holding ApS registered as owner (33.33%)
- OwnershipRO Bak Holding ApS registered as owner (10%)
- OwnershipUNIKUM Therapeutics ApS registered as owner (5%)
- OwnershipVolnay Therapeutics, LLC registered as owner (10%)
- OwnershipFallingwater Capital ApS is no longer registered as owner
- OwnershipAnders Laustsen Holding ApS is no longer registered as owner
- OwnershipUlrik Bjerl Nielsen is no longer registered as owner
- OwnershipMR Jakobsen Holding ApS is no longer registered as owner
- OwnershipMEDIC ADVICE ApS is no longer registered as owner
- OwnershipRO Bak Holding ApS is no longer registered as owner
20222 changesownership 1 · accounts 1
- OwnershipZOCCA CONSULTING ApS is no longer registered as owner
- AccountsAnnual report for 2021 published
20215 changescapital 1 · ownership 1 · accounts 1 · management 2
- CapitalShare capital changed from 40,000 DKK to 42,105 DKK
- OwnershipFallingwater Capital ApS registered as owner (5%)
- AccountsAnnual report for 2020 published
- ManagementRasmus Otkjær Bak appointed director
- ManagementSøren Sylvester Skjærbæk stepped down as director
202010 changesfounded 1 · management 3 · ownership 6
- FoundedRegistered as UNIKUM Therapeutics ApS
- ManagementSøren Sylvester Skjærbæk appointed director
- ManagementMartin Roelsgaard Jakobsen appointed board member
- ManagementUlrik Bjerl Nielsen appointed chair of the board
- OwnershipAnders Laustsen Holding ApS registered as owner (10%)
- OwnershipUlrik Bjerl Nielsen registered as owner (5%)
- OwnershipMR Jakobsen Holding ApS registered as owner (33.33%)
- OwnershipZOCCA CONSULTING ApS registered as owner (5%)
- OwnershipMEDIC ADVICE ApS registered as owner (10%)
- OwnershipRO Bak Holding ApS registered as owner (10%)
Related companies
Same industry in Aarhus
- Vestas Wind Systems A/S3,108 employees
- SEGES Innovation P/S520 employees
- Alx A/S109 employees
- NMD Pharma A/S64 employees
- Innovationscenter for Økologisk Landbrug P/S52 employees
- Cercare Medical A/S28 employees
Same people in management
- Actas A/Svia Søren Sylvester Skjærbæk
- NRGI A.m.b.a.via Søren Sylvester Skjærbæk
- Orbis Medicines ApSvia Søren Sylvester Skjærbæk
- de novo foundry ApSvia Søren Sylvester Skjærbæk
- Aloop Therapeutics ApSvia Søren Sylvester Skjærbæk
- Troya Therapeutics ApSvia Ulrik Bjerl Nielsen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.